Nektar Therapeutics (NKTR) Inventory Average (2011 - 2024)

Nektar Therapeutics' Inventory Average history runs 14 years deep, the most recent figure standing at $15.4 million for Q2 2024.

• In Q2 2024, Inventory Average fell 24.98% year-over-year to $15.4 million; the TTM figure through Jun 2024 stood at $15.4 million (down 24.98% YoY), while the FY2023 annual figure was $17.7 million, up 0.86% from the prior year.
• Inventory Average was $15.4 million for Q2 2024 at Nektar Therapeutics, down from $16.2 million in the prior quarter.
• In the past five years, Inventory Average ranged from a high of $20.5 million in Q2 2023 to a low of $12.7 million in Q3 2020.
• Historically, Inventory Average has averaged $16.1 million across 5 years, with a median of $15.7 million in 2021.
• The sharpest annual moves came in 2023 and 2024: Inventory Average rose 26.51% in 2023, then decreased 24.98% in 2024.
• A 5-year view of Inventory Average shows it stood at $14.1 million in 2020, then grew by 10.46% to $15.6 million in 2021, then advanced by 22.9% to $19.1 million in 2022, then declined by 18.37% to $15.6 million in 2023, then dropped by 1.69% to $15.4 million in 2024.
• The last three Inventory Average figures came in at $15.4 million (Q2 2024), $16.2 million (Q1 2024), and $15.6 million (Q4 2023), per Business Quant data.